Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveys

Bibliographic Details
Main Author: Kazdin, Alan E
Publication Date: 2024
Other Authors: Harris, Meredith G, Hwang, Irving, Sampson, Nancy A, Stein, Dan J, Viana, Maria Carmen, Vigo, Daniel V, Wu, Chi-Shin, Aguilar-Gaxiola, Sergio, Alonso, Jordi, Benjet, Corina, Bruffaerts, Ronny, Caldas-Almeida, José Miguel, Cardoso, Graca, Caselani, Elisa, Chardoul, Stephanie, Cía, Alfredo, de Jonge, Peter, Gureje, Oye, Haro, Josep Maria, Karam, Elie G, Kovess-Masfety, Viviane, Navarro-Mateu, Fernando, Piazza, Marina, Posada-Villa, José, Scott, Kate M, Stagnaro, Juan Carlos, Ten Have, Margreet, Torres, Yolanda, Vladescu, Cristian, Kessler, Ronald
Format: Other
Language: eng
Source: Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
Download full: http://hdl.handle.net/10362/174810
Summary: The World Health Organization World Mental Health (WMH) Survey Initiative is supported by the United States National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the United States Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical Inc., GlaxoSmithKline, and Bristol-Myers Squibb. We thank the staff of the WMH Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork, and consultation on data analysis. None of the funders had any role in the design, analysis, interpretation of results, or preparation of this paper. The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of the World Health Organization, other sponsoring organizations, agencies, or governments.
id RCAP_279853623e474d44a891f99d7ec76a27
oai_identifier_str oai:run.unl.pt:10362/174810
network_acronym_str RCAP
network_name_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository_id_str https://opendoar.ac.uk/repository/7160
spelling Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveysantidepressantsmajor depressive disordermedication discontinuationSDG 3 - Good Health and Well-beingThe World Health Organization World Mental Health (WMH) Survey Initiative is supported by the United States National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the United States Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical Inc., GlaxoSmithKline, and Bristol-Myers Squibb. We thank the staff of the WMH Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork, and consultation on data analysis. None of the funders had any role in the design, analysis, interpretation of results, or preparation of this paper. The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of the World Health Organization, other sponsoring organizations, agencies, or governments.BACKGROUND: Despite their documented efficacy, substantial proportions of patients discontinue antidepressant medication (ADM) without a doctor's recommendation. The current report integrates data on patient-reported reasons into an investigation of patterns and predictors of ADM discontinuation. METHODS: Face-to-face interviews with community samples from 13 countries (n = 30 697) in the World Mental Health (WMH) Surveys included n = 1890 respondents who used ADMs within the past 12 months. RESULTS: 10.9% of 12-month ADM users reported discontinuation-based on recommendation of the prescriber while 15.7% discontinued in the absence of prescriber recommendation. The main patient-reported reason for discontinuation was feeling better (46.6%), which was reported by a higher proportion of patients who discontinued within the first 2 weeks of treatment than later. Perceived ineffectiveness (18.5%), predisposing factors (e.g. fear of dependence) (20.0%), and enabling factors (e.g. inability to afford treatment cost) (5.0%) were much less commonly reported reasons. Discontinuation in the absence of prescriber recommendation was associated with low country income level, being employed, and having above average personal income. Age, prior history of psychotropic medication use, and being prescribed treatment from a psychiatrist rather than from a general medical practitioner, in comparison, were associated with a lower probability of this type of discontinuation. However, these predictors varied substantially depending on patient-reported reasons for discontinuation. CONCLUSION: Dropping out early is not necessarily negative with almost half of individuals noting they felt better. The study underscores the diverse reasons given for dropping out and the need to evaluate how and whether dropping out influences short- or long-term functioning.Comprehensive Health Research Centre (CHRC) - pólo NMSNOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNKazdin, Alan EHarris, Meredith GHwang, IrvingSampson, Nancy AStein, Dan JViana, Maria CarmenVigo, Daniel VWu, Chi-ShinAguilar-Gaxiola, SergioAlonso, JordiBenjet, CorinaBruffaerts, RonnyCaldas-Almeida, José MiguelCardoso, GracaCaselani, ElisaChardoul, StephanieCía, Alfredode Jonge, PeterGureje, OyeHaro, Josep MariaKaram, Elie GKovess-Masfety, VivianeNavarro-Mateu, FernandoPiazza, MarinaPosada-Villa, JoséScott, Kate MStagnaro, Juan CarlosTen Have, MargreetTorres, YolandaVladescu, CristianKessler, Ronald2024-11-07T22:37:23Z2024-012024-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/otherapplication/pdfhttp://hdl.handle.net/10362/174810eng0033-2917PURE: 74233165https://doi.org/10.1017/S0033291723002507info:eu-repo/semantics/openAccessreponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiainstacron:RCAAP2024-11-18T01:41:40Zoai:run.unl.pt:10362/174810Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireinfo@rcaap.ptopendoar:https://opendoar.ac.uk/repository/71602025-05-28T19:13:00.585472Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologiafalse
dc.title.none.fl_str_mv Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveys
title Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveys
spellingShingle Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveys
Kazdin, Alan E
antidepressants
major depressive disorder
medication discontinuation
SDG 3 - Good Health and Well-being
title_short Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveys
title_full Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveys
title_fullStr Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveys
title_full_unstemmed Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveys
title_sort Patterns, predictors, and patient-reported reasons for antidepressant discontinuation in the WHO World Mental Health Surveys
author Kazdin, Alan E
author_facet Kazdin, Alan E
Harris, Meredith G
Hwang, Irving
Sampson, Nancy A
Stein, Dan J
Viana, Maria Carmen
Vigo, Daniel V
Wu, Chi-Shin
Aguilar-Gaxiola, Sergio
Alonso, Jordi
Benjet, Corina
Bruffaerts, Ronny
Caldas-Almeida, José Miguel
Cardoso, Graca
Caselani, Elisa
Chardoul, Stephanie
Cía, Alfredo
de Jonge, Peter
Gureje, Oye
Haro, Josep Maria
Karam, Elie G
Kovess-Masfety, Viviane
Navarro-Mateu, Fernando
Piazza, Marina
Posada-Villa, José
Scott, Kate M
Stagnaro, Juan Carlos
Ten Have, Margreet
Torres, Yolanda
Vladescu, Cristian
Kessler, Ronald
author_role author
author2 Harris, Meredith G
Hwang, Irving
Sampson, Nancy A
Stein, Dan J
Viana, Maria Carmen
Vigo, Daniel V
Wu, Chi-Shin
Aguilar-Gaxiola, Sergio
Alonso, Jordi
Benjet, Corina
Bruffaerts, Ronny
Caldas-Almeida, José Miguel
Cardoso, Graca
Caselani, Elisa
Chardoul, Stephanie
Cía, Alfredo
de Jonge, Peter
Gureje, Oye
Haro, Josep Maria
Karam, Elie G
Kovess-Masfety, Viviane
Navarro-Mateu, Fernando
Piazza, Marina
Posada-Villa, José
Scott, Kate M
Stagnaro, Juan Carlos
Ten Have, Margreet
Torres, Yolanda
Vladescu, Cristian
Kessler, Ronald
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Comprehensive Health Research Centre (CHRC) - pólo NMS
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
RUN
dc.contributor.author.fl_str_mv Kazdin, Alan E
Harris, Meredith G
Hwang, Irving
Sampson, Nancy A
Stein, Dan J
Viana, Maria Carmen
Vigo, Daniel V
Wu, Chi-Shin
Aguilar-Gaxiola, Sergio
Alonso, Jordi
Benjet, Corina
Bruffaerts, Ronny
Caldas-Almeida, José Miguel
Cardoso, Graca
Caselani, Elisa
Chardoul, Stephanie
Cía, Alfredo
de Jonge, Peter
Gureje, Oye
Haro, Josep Maria
Karam, Elie G
Kovess-Masfety, Viviane
Navarro-Mateu, Fernando
Piazza, Marina
Posada-Villa, José
Scott, Kate M
Stagnaro, Juan Carlos
Ten Have, Margreet
Torres, Yolanda
Vladescu, Cristian
Kessler, Ronald
dc.subject.por.fl_str_mv antidepressants
major depressive disorder
medication discontinuation
SDG 3 - Good Health and Well-being
topic antidepressants
major depressive disorder
medication discontinuation
SDG 3 - Good Health and Well-being
description The World Health Organization World Mental Health (WMH) Survey Initiative is supported by the United States National Institute of Mental Health (NIMH; R01 MH070884), the John D. and Catherine T. MacArthur Foundation, the Pfizer Foundation, the United States Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center (FIRCA R03-TW006481), the Pan American Health Organization, Eli Lilly and Company, Ortho-McNeil Pharmaceutical Inc., GlaxoSmithKline, and Bristol-Myers Squibb. We thank the staff of the WMH Data Collection and Data Analysis Coordination Centres for assistance with instrumentation, fieldwork, and consultation on data analysis. None of the funders had any role in the design, analysis, interpretation of results, or preparation of this paper. The views and opinions expressed in this report are those of the authors and should not be construed to represent the views of the World Health Organization, other sponsoring organizations, agencies, or governments.
publishDate 2024
dc.date.none.fl_str_mv 2024-11-07T22:37:23Z
2024-01
2024-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/other
format other
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/174810
url http://hdl.handle.net/10362/174810
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0033-2917
PURE: 74233165
https://doi.org/10.1017/S0033291723002507
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
instname:FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron:RCAAP
instname_str FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
instacron_str RCAAP
institution RCAAP
reponame_str Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
collection Repositórios Científicos de Acesso Aberto de Portugal (RCAAP)
repository.name.fl_str_mv Repositórios Científicos de Acesso Aberto de Portugal (RCAAP) - FCCN, serviços digitais da FCT – Fundação para a Ciência e a Tecnologia
repository.mail.fl_str_mv info@rcaap.pt
_version_ 1833597948823339008